ELAN logo

Elanco Animal Health Incorporated

ELAN
Healthcare|Drug Manufacturers - Specialty & Generic|US
$25.74
+2.06 (+8.70%)
DCF Value
$4.60
Cash / Share
$0.93

About

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.

Stock Price

+19.6%(1Y)
1M
+14.2%
3M
+16.4%
6M
+8.8%
YTD
+13.7%
1Y
+15.6%
3Y
+137.2%
5Y
-22.6%

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

Key Facts

Market Cap$12.86B
Employees9,400 (+4% YoY)
CEOJeffrey N. Simmons
IPO DateSep 20, 2018
Beta1.72
52-Week Range$19.4 – $27.98
Avg Volume5,883,467
ExchangeNYSE
Websiteelanco.com

Ownership

Float99.0%
Shares Outstanding499.6M

Recent Insider Trades

Preston JamieOTHER
Nov 3, 20260 shares
Modi Rajeev A.AWARD
Oct 30, 202664.047 shares
VanHimbergen Robert MAWARD
Oct 30, 20268.544 shares
Simmons Jeffrey NAWARD
Oct 30, 2026122.59 shares
Modi Rajeev A.AWARD
Oct 16, 202662.715 shares

Peers

IDXXIDEXX Laboratories, Inc.
$53.26B
MRKMerck & Co., Inc.
$361.96B
NEOGNeogen Corporation
$2.57B
ORINYOrion Oyj
$32.41B
PAHCPhibro Animal Health Corporation
$1.34B
ZTSZoetis Inc.
$32.81B
Data last updated: Nov 9, 2026, 04:08 AM